Literature DB >> 7700253

Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes.

D J Henry1, D K Grandy, H A Lester, N Davidson, C Chavkin.   

Abstract

Xenopus oocytes expressed kappa-opioid specific binding sites after injection of cRNA prepared from a clone of the rat kappa-opioid receptor. Coinjection of kappa receptor cRNA with cRNA coding for a G protein-linked, inwardly rectifying, K+ channel (GIRK1, or KGA) resulted in oocytes that responded to the kappa agonist U-69593 by activating a large (1.0-1.5-microA) K+ current. U-69593 exhibited an EC50 of 260 +/- 50 nM and was blocked by the opioid antagonists norbinaltorphimine and naloxone. The kappa agonist bremazocine was 200-fold more potent than U-69593 in eliciting K+ current but exhibited a partial agonist profile in this expression system. The present results indicate that stimulation of inwardly rectifying K+ channels may be a potential effector mechanism for kappa-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7700253

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  32 in total

1.  TrkB activation by brain-derived neurotrophic factor inhibits the G protein-gated inward rectifier Kir3 by tyrosine phosphorylation of the channel.

Authors:  S L Rogalski; S M Appleyard; A Pattillo; G W Terman; C Chavkin
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  Eicosanoids inhibit the G-protein-gated inwardly rectifying potassium channel (Kir3) at the Na+/PIP2 gating site.

Authors:  S L Rogalski; C Chavkin
Journal:  J Biol Chem       Date:  2001-02-07       Impact factor: 5.157

Review 3.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

4.  6'-Guanidinonaltrindole (6'-GNTI) is a G protein-biased κ-opioid receptor agonist that inhibits arrestin recruitment.

Authors:  Marie-Laure Rives; Mary Rossillo; Lee-Yuan Liu-Chen; Jonathan A Javitch
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

5.  Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists.

Authors:  P A Claude; D R Wotta; X H Zhang; P L Prather; T M McGinn; L J Erickson; H H Loh; P Y Law
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 6.  Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides.

Authors:  B L Kieffer
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

7.  [35S]GTP gamma S binding: a tool to evaluate functional activity of a cloned opioid receptor transiently expressed in COS cells.

Authors:  K Befort; L Tabbara; B L Kieffer
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

Review 8.  Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.

Authors:  Anupam Banerjee; Marianne Strazza; Brian Wigdahl; Vanessa Pirrone; Olimpia Meucci; Michael R Nonnemacher
Journal:  J Neurovirol       Date:  2011-07-07       Impact factor: 2.643

Review 9.  Molecular and genetic substrates linking stress and addiction.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Brain Res       Date:  2009-11-10       Impact factor: 3.252

10.  Epigenetic regulation of kappa opioid receptor gene in neuronal differentiation.

Authors:  S W Park; Y He; S G Ha; H H Loh; L-N Wei
Journal:  Neuroscience       Date:  2008-01-16       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.